SavedAdd your journal

Journals / The Journal of Pediatric Research / 2020 / Cilt: 7 - Sayı: 2

Serum Bone Alkaline Phosphatase and Growth Hormone Levels May Help as a Diagnostic Criteria for Children with Amelogenesis Imperfecta

DİDEM ÖNER ÖZDAŞ
Sevgi ZORLU
Gamze AREN
Pages
110–113
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Subjects with AI have statistically significant abnormal blood BALP and GHlevels and the presence of an Additional syndrome other than AI did not affect the results.Conclusion: Pediatricians may have a key role in early AI diagnosis via the evaluation of abnormal BALP and GH levels in blood tests and mayhelp in providing comprehensive dental treatment in terms of prevention, prognosis and restoration of teeth in children with AI.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The Amelogenesis Imperfecta (AI) term includes numerous inherited congenital enamel defects indicating clinical and geneticheterogeneity.
📊
Key Findings & Data:The aim of the present study was to emphasize the importance of the potential prediction of AI via biochemical parameters.Materials and Methods: In total, 50 children were assessed in the study.
💡
Conclusion & Impact:Subjects with AI have statistically significant abnormal blood BALP and GHlevels and the presence of an Additional syndrome other than AI did not affect the results.Conclusion: Pediatricians may have a key role in early AI diagnosis via the evaluation of abnormal BALP and GH levels in blood tests and mayhelp in providing comprehensive dental treatment in terms of prevention, prognosis and restoration of teeth in children with AI.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aim: The Amelogenesis Imperfecta (AI) term includes numerous inherited congenital enamel defects indicating clinical and geneticheterogeneity. The aim of the present study was to emphasize the importance of the potential prediction of AI via biochemical parameters.Materials and Methods: In total, 50 children were assessed in the study. The subjects included 13 syndromic AI, 22 isolated AI and 15 healthychildren with a mean-age of 12.01±3.79 years old. The bone alkaline Phosphatase (BALP) and growth hormone (GH) blood levels of the childrenwere evaluated. All data were statistically analysed by the SPSS 15.0 programme, one-way ANOVA and chi-square tests.Results: 72.7% of syndromic AI and 47.6% of isolated AI group children have higher than normal BALP levels; 33% of syndromic AI and 28% ofisolated AI group children have lower than normal blood GH levels. Subjects with AI have statistically significant abnormal blood BALP and GHlevels and the presence of an Additional syndrome other than AI did not affect the results.Conclusion: Pediatricians may have a key role in early AI diagnosis via the evaluation of abnormal BALP and GH levels in blood tests and mayhelp in providing comprehensive dental treatment in terms of prevention, prognosis and restoration of teeth in children with AI.

🔖

Cite This Article

ÖZDAŞ, D. Ö., ZORLU, S., AREN, G. (2020). Serum Bone Alkaline Phosphatase and Growth Hormone Levels May Help as a Diagnostic Criteria for Children with Amelogenesis Imperfecta. The Journal of Pediatric Research, Cilt: 7 - Sayı: 2, 110–113. https://ajindex.com/articles/362715

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Rodrigo S. Lacruz, Stefan Habelitz, J. Timothy Wright, Michael L. Paine Dental Enamel Formation and Implications For Oral Health and Disease. Physiol Rev 2017;97:939-93
  2. Jussila M, Juuri E, Thesleff I. Tooth Morphogenesis and Renewal. Huang GT-J. Thesleff I. Stem Cells in Craniofacial Development and Regeneration. Edition, Wiley-Blackwell, Singapore,2013.109-34
  3. Poornima P, Katkade S, Mohamed RN, Mallikarjuna R. Amelogenesis Imperfecta With Bilateral Nephrocalcinosis. BMJ Case Rep 2013;2013
  4. Smith. CEL, Poulter JA, Antanaviciute A, et al. Amelogenesis Imperfecta; Genes, Proteins and Pathways. Front Physiol 2017;8:435
  5. Coffield KD, Phillips C, Brady M, Roberts MW, Strauss RP, Wright JT. The Psychosocial Impact of Developmental Dental Defects in People With Hereditary Amelogenesis Imperfecta. J Am Dent Assoc 2005;136:620-30
  6. Koch G, Poulsen S. Pediatric Dentistry-a clinical approach. 1st ed, Munksgaard, Blackwell publishing,2003.276-80
  7. Altug-Atac AT, Erdem D. Prevalence and Distribution of Dental Anomalies in Orthodontic Patients. Am J Orthod Dentofacial Orthop 2007;131:510-4
  8. Prasad MK, Geoffroy V, Vicaire S, et al. A Targeted Next- Generation Sequencing Assay For The Molecular Diagnosis of Genetic Disorders With Orodental Involvement. J Med Genet 2016;53:98-110
  9. Jaskoll T, Abichaker G, Htet K, et al. Cytomegalovirus Induces Stage Dependent Enamel Defects and Misexpression of Amelogenin, Enamelin and Dentin Sialophosphoprotein in Developing Mouse Molars. Cells Tissues Organs 2010;192:221-39
  10. Takamori K, Hosokawa R, Xu X, Deng X, Bringas P Jr, Chai Y. Epithelial Fibroblast Growth Factor Receptor 1 Regulates Enamel Formation. J Dent Res 2008;87:238-43
  11. Paula LM, Melo NS, Silva Guerra EN, Mestrinho DH, Acevedo AC. Case Report of A Rare Syndrome Associating Amelogenesis Imperfecta and Nephrocalcinosis In A Consanguineous Family. Arch Oral Biol 2005;50:237-42
  12. Aren G, Ozdemir D, Firatli S, Uygur C, Sepet E, Firatli E. Evaluation of Oral And Systemic Manifestations in An Amelogenesis Imperfecta Population. J Dent 2003;31:585-91
  13. Aren G, Ozdaş DO, Zorlu SE. Is Amelogenesis Imperfecta a Signal of Systemic Disorders? A Brief Review of Literature. J Int Dent Med Res 2012;5:49-54
  14. Wang XP, Suomalainen M, Jorgez CJ, Matzuk MM, Werner S, Thesleff I. Follistatin Regulates Enamel Patterning in Mouse Incisors By Asymmetrically Inhibiting BMP Signaling and Ameloblast Differentiation. Dev Cell 2004;7:719-30
  15. AAPD Clinical p